Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2010
06/15/2010US7736636 Mixture of nicotine polymer and vasodilator; promote angiogenesis; therapy for erectile dysfunction, cardiovascular disorders, strokes
06/15/2010US7736622 Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
06/15/2010US7735485 Dry powder inhalation system for transpulmonary administration
06/15/2010CA2578709C Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents
06/15/2010CA2481868C Preparation of powder agglomerates
06/15/2010CA2410253C Regulating lipid levels via the zmax1 or hbm gene
06/15/2010CA2407072C Taste masking coating composition
06/15/2010CA2404696C Medicament containing tissue inhibitor of metalloproteinases-2 (timp-2) as an osteoanabolically active substance
06/15/2010CA2402219C Novel echinocandin derivatives, preparation method and use thereof as fungicides
06/15/2010CA2366833C Hemoglobin-antioxidant conjugates
06/15/2010CA2299495C Process for preparing growth hormone secretagogues
06/15/2010CA2294472C Torsin, torsin genes, and methods of use
06/15/2010CA2285939C Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
06/15/2010CA2269109C Protease for activating clotting factor vii
06/15/2010CA2250000C Methods of modulating melanin synthesis
06/10/2010WO2010065751A2 Formulations of guanylate cyclase c agonists and methods of use
06/10/2010WO2010065735A2 Methods and compositions for treating p.acnes
06/10/2010WO2010065613A2 Annexina2 as immunological target
06/10/2010WO2010065572A1 Sstr1-selective analogs
06/10/2010WO2010065563A2 Apratoxin therapeutic agents: mechanism and methods of treatment
06/10/2010WO2010065524A2 Methods and compositions for the treatment of fluid retention disorders
06/10/2010WO2010065491A2 Methods of treating inflammatory disorders
06/10/2010WO2010065461A1 Tri-peptide inhibitors of serine elastases
06/10/2010WO2010065439A1 Variants of fibroblast growth factor 21
06/10/2010WO2010065437A1 Modulation of olfml-3 mediated angiogenesis
06/10/2010WO2010065346A1 Exfoliation of graphite using ionic liquids
06/10/2010WO2010065342A1 Angiocidin inhibition of tumor cell growth
06/10/2010WO2010065206A1 Polypeptide for treating or preventing adhesions
06/10/2010WO2010065116A2 The use of il-27-p28 to antagonize il-6 mediated signaling
06/10/2010WO2010065085A2 Methods and compositions for treating or preventing pruritis
06/10/2010WO2010064838A2 Cell permeable p53 recombinant protein, polynucleotide encoding the same, and anti-cancer composition containing the same as active ingredient
06/10/2010WO2010064714A1 Nutrient composition
06/10/2010WO2010064522A1 Inhalant comprising modified superoxide dismutase
06/10/2010WO2010064258A2 Pharmaceutical formulations of interferon conjugates
06/10/2010WO2010064243A1 GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
06/10/2010WO2010064132A1 Mutants of staphylokinase carrying amino and carboxy-terminal extensions for polyethylene glycol conjugation
06/10/2010WO2010063994A1 Non-surgical improvement of scars
06/10/2010WO2010063847A1 Compositions for potentiating apoposis signals in tumour cells
06/10/2010WO2010063839A2 Targets for treatment of chlamydial infections
06/10/2010WO2010063698A1 Treatment of oncological diseases
06/10/2010WO2010063696A1 Use of alkanoyl l-carnitine in combination with chemotherapeutic agents for the treatment of neoplasms
06/10/2010WO2010063652A1 Methods and uses involving heme binding protein 1
06/10/2010WO2010063250A1 Antimicrobial peptides made of hydra
06/10/2010WO2010063237A1 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance
06/10/2010WO2010063124A1 Peptide therapeutic conjugates and uses thereof
06/10/2010WO2010063123A1 Leptin and leptin analog conjugates and uses thereof
06/10/2010WO2010063122A1 Conjugates of neurotensin or neurotensin analogs and uses thereof
06/10/2010WO2010044095A3 Proline rich polypeptide from colostrum
06/10/2010WO2010043772A8 Method of protecting cells
06/10/2010WO2010036408A3 Lysk endolysin is synergistic with lysostaphin against mrsa
06/10/2010WO2010028845A3 Use of an ang-(1-7) receptor agonist in acute lung injury
06/10/2010WO2010019954A3 Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs
06/10/2010WO2010014616A3 Prominin-1 peptide fragments and uses thereof
06/10/2010WO2010013012A4 Hypothermia inducing polypeptides and uses thereof
06/10/2010WO2009149486A3 Compounds for treating beta-amyloidoses
06/10/2010WO2009149485A3 Compounds for treating amyloidoses
06/10/2010WO2009149161A3 Chimeric natriuretic polypeptides and methods for inhibiting cardiac remodeling
06/10/2010WO2009115658A3 Use of a caspase-1 inhibitor for treating atherosclerotic plaque
06/10/2010WO2009065561A8 System for delivery into a xcr1 positive cell and uses thereof
06/10/2010US20100146648 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
06/10/2010US20100145441 Therapeutic agents for angiogenesis-related diseases comprising chondromodulin-i as active ingredient
06/10/2010US20100145301 Spray administration of compositions including active agents such as peptides to the gastrointestinal tract
06/10/2010US20100145255 System And Method For Reducing The Appearance Of Fine Lines And Wrinkles And Improving the Skin Tone
06/10/2010US20100145071 Small molecule inhibitors of rotamase enzyme activity
06/10/2010US20100145030 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
06/10/2010US20100145017 Method of producing interferon-b complex
06/10/2010US20100145011 Alpha-conotoxin peptides
06/10/2010US20100144841 Control of nk cell function and survival by modulation of ship activity
06/10/2010US20100144837 Diagnosis and treatment of malignant neoplasms
06/10/2010US20100144804 Polymorph of a Pharmaceutical
06/10/2010US20100144691 Treatment of Female Fertility Conditions Through Modulation of the Autonomic Nervous System
06/10/2010US20100144677 Method for screening agents for the treatment of diabetes
06/10/2010US20100144650 Dimeric iap inhibitors
06/10/2010US20100144649 Compounds for enzyme inhibition
06/10/2010US20100144648 Compounds for enzyme inhibition
06/10/2010US20100144647 Dual Acting Prodrugs
06/10/2010US20100144646 Method of diagnosing and treating asthma
06/10/2010US20100144645 Compositions and methods for enhancing analgesic potency of covalently bound-compounds, attenuating its adverse side effects, and preventing their abuse
06/10/2010US20100144644 Metal-binding compounds and uses therefor
06/10/2010US20100144643 Polymeric Biosufactants
06/10/2010US20100144642 Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions
06/10/2010US20100144641 Compositions Having Antiangiogenic Activity and Uses Thereof
06/10/2010US20100144640 Molecules designated b7l-1
06/10/2010US20100144639 Use of inhibitors of the egfr-mediated signal transduction for the treatment of benign prostatic hyperplasia (bph) / prostatic hypertrophy
06/10/2010US20100144638 Glucagon-like peptide-1 secretagogue, glucagon-like peptide-1 secretagogue food or drink, inhibitor of postprandial rise in blood glucose, and inhibitory food or drink of postprandial rise in blood glucose
06/10/2010US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
06/10/2010US20100144636 Peptides derived from ras-p21 and uses therefor
06/10/2010US20100144635 Methods and compositions to treat myocardial conditions
06/10/2010US20100144634 Compositions and Methods for Modulation of ADAMTS13 Activity
06/10/2010US20100144633 Chloroplast expression of membrane proteins
06/10/2010US20100144632 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity
06/10/2010US20100144631 Concentrated Protein Preparations of Bone Morphogenetic Proteins and Methods of Use Thereof
06/10/2010US20100144630 Compositions, methods and uses for inhibition and/or treatment of influenza infection
06/10/2010US20100144629 Method to treat inflammation
06/10/2010US20100144628 Hepatopoietin and use thereof
06/10/2010US20100144627 Methods for modulating set and uses thereof
06/10/2010US20100144626 Treatment of Multi-Drug Resistant Bacterial Infections
06/10/2010US20100144625 Organic Compounds
06/10/2010US20100144624 Process for the preparation of compositions of at1 receptor antagonist and angiotensin-(1-7)
06/10/2010US20100144623 C-Terminal Domain Truncation of mGluR1a By Calpain and Uses Thereof
1 ... 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 ... 3163